1-8 of 8
Alain Ravaud
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma

Nizar M. Tannir, Sabina Signoretti, Toni K. Choueiri, David F. McDermott, Robert J. Motzer, Abdallah Flaifel, Jean-Christophe Pignon, Miriam Ficial, Osvaldo Arén Frontera, Saby George, Thomas Powles, Frede Donskov, Michael R. Harrison, Philippe Barthélémy, Scott S. Tykodi, Judit Kocsis, Alain Ravaud, Jeronimo R. Rodriguez-Cid, Sumanta K. Pal, Andre M. Murad, Yuko Ishii, Shruti Shally Saggi, M. Brent McHenry, Brian I. Rini
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (1): 78–86.
https://doi.org/10.1158/1078-0432.CCR-20-2063
Published: 04 January 2021
View article titled, Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma
Open the PDF for Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-free Survival in Postnephrectomy High-risk Locoregional Renal Cell Carcinoma: Analysis of the S-TRAC Trial

Anup Patel, Alain Ravaud, Robert J. Motzer, Allan J. Pantuck, Michael Staehler, Bernard Escudier, Jean-François Martini, Mariajose Lechuga, Xun Lin, Daniel J. George
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (18): 4863–4868.
https://doi.org/10.1158/1078-0432.CCR-20-0704
Published: 15 September 2020
View article titled, Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-free Survival in Postnephrectomy High-risk Locoregional Renal Cell Carcinoma: Analysis of the S-TRAC Trial
Open the PDF for Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-free Survival in Postnephrectomy High-risk Locoregional Renal Cell Carcinoma: Analysis of the S-TRAC Trial in another window
Journal Articles

Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis

Daniel J. George, Jean-Francois Martini, Michael Staehler, Robert J. Motzer, Ahmed Magheli, Frede Donskov, Bernard Escudier, Sherry Li, Michelle Casey, Olga Valota, Brigitte Laguerre, Allan J. Pantuck, Hardev S. Pandha, Anup Patel, Maria Lechuga, Alain Ravaud
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (4): 1165–1173.
https://doi.org/10.1158/1078-0432.CCR-18-1724
Published: 15 February 2019
View article titled, Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis
Open the PDF for Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis in another window
Includes: Supplementary data
Journal Articles

Sunitinib Prior to Planned Nephrectomy in Metastatic Renal Cell Carcinoma: Angiogenesis Biomarkers Predict Clinical Outcome in the Prospective Phase II PREINSUT Trial

Laetitia Mauge, Arnaud Mejean, Laure Fournier, Helena Pereira, Marie-Christine Etienne-Grimaldi, Emeline Levionnois, Armelle Caty, Sophie Abadie-Lacourtoisie, Stéphane Culine, Sylvestre Le Moulec, Claude Linassier, Christine Théodore, Alain Ravaud, Laurence Albiges, Abel Grine, Eric Tartour, Gérard Milano, Anne-Sophie Gille, Virginie Verkarre, Dominique Helley, Stéphane Oudard
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (22): 5534–5542.
https://doi.org/10.1158/1078-0432.CCR-18-1045
Published: 15 November 2018
View article titled, Sunitinib Prior to Planned Nephrectomy in Metastatic Renal Cell Carcinoma: Angiogenesis Biomarkers Predict Clinical Outcome in the Prospective Phase II PREINSUT Trial
Open the PDF for Sunitinib Prior to Planned Nephrectomy in Metastatic Renal Cell Carcinoma: Angiogenesis Biomarkers Predict Clinical Outcome in the Prospective Phase II PREINSUT Trial in another window
Includes: Supplementary data
Journal Articles

Validation of the 16-Gene Recurrence Score in Patients with Locoregional, High-Risk Renal Cell Carcinoma from a Phase III Trial of Adjuvant Sunitinib

Brian I. Rini, Bernard Escudier, Jean-Francois Martini, Ahmed Magheli, Christer Svedman, Margarita Lopatin, Dejan Knezevic, Audrey D. Goddard, Phillip G. Febbo, Rachel Li, Xun Lin, Olga Valota, Michael Staehler, Robert J. Motzer, Alain Ravaud
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (18): 4407–4415.
https://doi.org/10.1158/1078-0432.CCR-18-0323
Published: 14 September 2018
View article titled, Validation of the 16-Gene Recurrence Score in Patients with Locoregional, High-Risk Renal Cell Carcinoma from a Phase III Trial of Adjuvant Sunitinib
Open the PDF for Validation of the 16-Gene Recurrence Score in Patients with Locoregional, High-Risk Renal Cell Carcinoma from a Phase III Trial of Adjuvant Sunitinib in another window
Includes: Supplementary data
Journal Articles

Immune Biomarkers Predictive for Disease-Free Survival with Adjuvant Sunitinib in High-Risk Locoregional Renal Cell Carcinoma: From Randomized Phase III S-TRAC Study

Daniel J. George, Jean-François Martini, Michael Staehler, Robert J. Motzer, Ahmed Magheli, Bernard Escudier, Paola Gerletti, Sherry Li, Michelle Casey, Brigitte Laguerre, Hardev S. Pandha, Allan J. Pantuck, Anup Patel, Maria J. Lechuga, Alain Ravaud
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (7): 1554–1561.
https://doi.org/10.1158/1078-0432.CCR-17-2822
Published: 02 April 2018
View article titled, Immune Biomarkers Predictive for Disease-Free Survival with Adjuvant Sunitinib in High-Risk Locoregional Renal Cell Carcinoma: From Randomized Phase III S-TRAC Study
Open the PDF for Immune Biomarkers Predictive for Disease-Free Survival with Adjuvant Sunitinib in High-Risk Locoregional Renal Cell Carcinoma: From Randomized Phase III S-TRAC Study in another window
Journal Articles

Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer

Bernard Escudier, Viktor Grünwald, Alain Ravaud, Yen-Chuan Ou, Daniel Castellano, Chia-Chi Lin, Jürgen E. Gschwend, Andrea Harzstark, Sarah Beall, Nicoletta Pirotta, Matthew Squires, Michael Shi, Eric Angevin
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (11): 3012–3022.
https://doi.org/10.1158/1078-0432.CCR-13-3006
Published: 29 May 2014
View article titled, Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer
Open the PDF for Phase II Results of Dovitinib (TKI258) in Patients with Metastatic Renal Cell Cancer in another window
Includes: Supplementary data
Journal Articles

Randomized Study of Intravenous versus Subcutaneous Interleukin-2, and IFNα in Patients with Good Prognosis Metastatic Renal Cancer

Sylvie Négrier, David Perol, Alain Ravaud, Jacques O. Bay, Stéphane Oudard, Sylvie Chabaud, Pierre Fargeot, Remy Delva, Gael Deplanque, Gwenaelle Gravis, Bernard Escudier, for the French Immunotherapy Group
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (18): 5907–5912.
https://doi.org/10.1158/1078-0432.CCR-08-0236
Published: 14 September 2008
View article titled, Randomized Study of Intravenous versus Subcutaneous Interleukin-2, and IFNα in Patients with Good Prognosis Metastatic Renal Cancer
Open the PDF for Randomized Study of Intravenous versus Subcutaneous Interleukin-2, and IFNα in Patients with Good Prognosis Metastatic Renal Cancer in another window